Sarah Gerlo

3.7k total citations · 1 hit paper
54 papers, 2.8k citations indexed

About

Sarah Gerlo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sarah Gerlo has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 21 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Sarah Gerlo's work include Cytokine Signaling Pathways and Interactions (11 papers), Immune Cell Function and Interaction (9 papers) and Immune Response and Inflammation (9 papers). Sarah Gerlo is often cited by papers focused on Cytokine Signaling Pathways and Interactions (11 papers), Immune Cell Function and Interaction (9 papers) and Immune Response and Inflammation (9 papers). Sarah Gerlo collaborates with scholars based in Belgium, France and United States. Sarah Gerlo's co-authors include Jan Tavernier, Guy Haegeman, Éric Chevet, M. Maurel, Krzysztof Kolmus, Ron Kooijman, Anneleen Spooren, Guy Laureys, Jacques De Keyser and Wim Vanden Berghe and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Sarah Gerlo

53 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Getting RIDD of RNA: IRE1 in cell fate regulation

2014 453 citations Jan Tavernier, Sarah Gerlo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Gerlo Belgium	27	946	679	567	387	356	54	2.8k
Chia‐Ling Chen Taiwan	34	1.5k 1.6×	621 0.9×	251 0.4×	353 0.9×	360 1.0×	118	3.1k
Markus Schneemann Switzerland	25	868 0.9×	658 1.0×	269 0.5×	352 0.9×	286 0.8×	57	3.0k
Carmen García‐Rodríguez Spain	35	1.7k 1.8×	836 1.2×	188 0.3×	238 0.6×	334 0.9×	72	3.5k
Anjaparavanda P. Naren United States	37	2.3k 2.4×	321 0.5×	605 1.1×	247 0.6×	427 1.2×	108	4.6k
Jin Hee Kim South Korea	30	1.2k 1.3×	577 0.8×	227 0.4×	192 0.5×	323 0.9×	121	3.0k
Uh‐Hyun Kim South Korea	37	2.0k 2.1×	479 0.7×	396 0.7×	357 0.9×	408 1.1×	114	4.0k
Gustavo Batista Menezes Brazil	33	1.3k 1.3×	1.5k 2.2×	169 0.3×	585 1.5×	266 0.7×	133	4.1k
Bernard Robaye Belgium	40	1.9k 2.0×	968 1.4×	183 0.3×	294 0.8×	311 0.9×	100	4.7k
B Gajkowska Poland	28	1.5k 1.6×	292 0.4×	212 0.4×	369 1.0×	242 0.7×	149	2.7k

Countries citing papers authored by Sarah Gerlo

Since Specialization

Citations

This map shows the geographic impact of Sarah Gerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Gerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Gerlo more than expected).

Fields of papers citing papers by Sarah Gerlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Gerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Gerlo. The network helps show where Sarah Gerlo may publish in the future.

Co-authorship network of co-authors of Sarah Gerlo

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Gerlo. A scholar is included among the top collaborators of Sarah Gerlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Gerlo. Sarah Gerlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheerder, Marie‐Angélique De, Virginie Mortier, Chris Verhofstede, et al.. (2024). Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir. Frontiers in Immunology. 14. 1337316–1337316. 9 indexed citations

Snippenberg, Willem van, Sofie Rutsaert, Marie‐Angélique De Scheerder, et al.. (2024). Integrative Assessment of Total and Intact HIV-1 Reservoir by a 5-Region Multiplexed Rainbow DNA Digital PCR Assay. Clinical Chemistry. 71(1). 203–214. 3 indexed citations

Scheerder, Marie‐Angélique De, Sophie Degroote, Maja Kiselinova, et al.. (2024). In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA). The Journal of Infectious Diseases. 231(1). e91–e100. 2 indexed citations

Gerlo, Sarah, Steven Callens, Stefan Heytens, et al.. (2022). Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population. Vaccines. 10(2). 260–260. 11 indexed citations

Lint, Sandra Van, Elianne Burg, Stéphane Plaisance, et al.. (2021). Selective IL-1 activity on CD8⁺ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication. Journal for ImmunoTherapy of Cancer. 9(11). e003293–e003293. 15 indexed citations

Hoecke, Lien Van, Elianne Burg, Sandra Van Lint, et al.. (2020). Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. npj Vaccines. 5(1). 64–64. 23 indexed citations

Cauwels, Anje, Sandra Van Lint, Franciane Paul, et al.. (2017). Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments. Cancer Research. 78(2). 463–474. 75 indexed citations

Kolmus, Krzysztof, Marleen Van Troys, Christophe Ampè, et al.. (2014). β-Agonists Selectively Modulate Proinflammatory Gene Expression in Skeletal Muscle Cells via Non-Canonical Nuclear Crosstalk Mechanisms. PLoS ONE. 9(3). e90649–e90649. 8 indexed citations

Palagani, Ajay, Ken Op de Beeck, Stefan Naulaerts, et al.. (2014). Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells. PLoS ONE. 9(12). e113842–e113842. 36 indexed citations

10.

Kolmus, Krzysztof, Jan Tavernier, & Sarah Gerlo. (2014). β2-Adrenergic receptors in immunity and inflammation: Stressing NF-κB. Brain Behavior and Immunity. 45. 297–310. 107 indexed citations

11.

Danneels, Ellen, Sarah Gerlo, Karen Heyninck, et al.. (2014). How the Venom from the Ectoparasitoid Wasp Nasonia vitripennis Exhibits Anti-Inflammatory Properties on Mammalian Cell Lines. PLoS ONE. 9(5). e96825–e96825. 29 indexed citations

12.

Acker, Tim Van, Sven Eyckerman, Lieselotte Vande Walle, et al.. (2013). The Small GTPase Arf6 Is Essential for the Tram/Trif Pathway in TLR4 Signaling. Journal of Biological Chemistry. 289(3). 1364–1376. 26 indexed citations

13.

Liberman, Ana C., V. Ferraz-de-Paula, João Palermo‐Neto, et al.. (2012). Correction: Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells. PLoS ONE. 7(5). 5 indexed citations

14.

Spooren, Anneleen, Ron Kooijman, Béatrice Lintermans, et al.. (2010). Cooperation of NFκB and CREB to induce synergistic IL-6 expression in astrocytes. Cellular Signalling. 22(5). 871–881. 60 indexed citations

15.

Laureys, Guy, Ralph Clinckers, Sarah Gerlo, et al.. (2010). Astrocytic β2-adrenergic receptors: From physiology to pathology. Progress in Neurobiology. 91(3). 189–199. 47 indexed citations

16.

Beck, Ilse M., Wim Vanden Berghe, Sarah Gerlo, et al.. (2008). Glucocorticoids and mitogen- and stress-activated protein kinase 1 inhibitors: Possible partners in the combat against inflammation. Biochemical Pharmacology. 77(7). 1194–1205. 20 indexed citations

17.

Gerlo, Sarah, Guy Haegeman, & Wim Vanden Berghe. (2008). Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells. Cellular Signalling. 20(8). 1489–1496. 37 indexed citations

18.

Gerlo, Sarah, Peggy Verdood, & Ron Kooijman. (2005). Tumor necrosis factor-α activates the extrapituitary PRL promoter in myeloid leukemic cells. Journal of Neuroimmunology. 172(1-2). 206–210. 9 indexed citations

19.

Gerlo, Sarah, Peggy Verdood, Birgit Gellersen, Elisabeth L. Hooghe‐Peters, & Ron Kooijman. (2004). Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5′-Monophosphate-Mediated Signaling Pathways. The Journal of Immunology. 173(10). 5952–5962. 41 indexed citations

20.

Gerlo, Sarah, et al.. (2003). Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells. Journal of Neuroimmunology. 135(1-2). 107–116. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact